The results showed that the total protein expression of PXDN was significantly higher in PAAD, HCC, GBM, HNSC, Clear cell RCC, breast cancer, and ovarian cancer tissues than in normal tissues (Figure 1C). This evidence concerns the gene PXDN and ovarian cancer.